• About
  • Advertise
  • Careers
  • Write for us
  • Contact
  • Terms of service
Thursday, June 30, 2022
The Millennial Source
TMS
Home WORLD

Why it matters that the US wants to waive patent protections for the COVID-19 vaccines

byJoseph Lyttleton
May 9, 2021
in WORLD
Why it matters that the US wants to waive patent protections for the COVID-19 vaccines

Source: Kevin Lamarque, Reuters

Share on FacebookShare on TwitterShare on Linkedin
This move is likely a good thing for India and other countries where the pandemic is getting worse because such countries are struggling to produce and administer enough vaccines.

  • Following weeks of pressure, as the coronavirus pandemic worsened in many countries around the world, the Biden administration said it approves waiving patent protections for COVID-19 vaccines.
  • The decision was announced on Wednesday, May 5, by United States Trade Representative Katherine Tai.
  • “This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures,” Tai said.

These extraordinary times and circumstances of call for extraordinary measures.

The US supports the waiver of IP protections on COVID-19 vaccines to help end the pandemic and we’ll actively participate in @WTO negotiations to make that happen. pic.twitter.com/96ERlboZS8

— Ambassador Katherine Tai (@AmbassadorTai) May 5, 2021
  • The announcement was celebrated by those who say it will help bring the pandemic to an end.
  • But it’s also been criticized by those who claim it won’t make a difference in the short-term and could flood the market with low quality vaccines in the long-term.

Why waive the COVID-19 vaccine patents?

  • Just a couple weeks ago, the Biden administration said it was considering but not yet committed to the idea of waiving patent rights for the COVID-19 vaccines.
  • Waiving the rights to the patents means that the pharmaceutical companies’ intellectual property (or the “recipes” for the vaccines) would be available publicly.
  • The increasing pressure to act, including from members of his own party, appears to have pushed President Joe Biden to make this decision.

Waive the vaccine patents, fund vaccine distribution worldwide.

Lives are on the line.

— Ilhan Omar (@IlhanMN) April 28, 2021
  • This move is likely a good thing for India and other countries where the pandemic is getting worse because such countries are struggling to produce and administer enough vaccines.
  • Waiving the patents on the vaccines means that more vaccines will be able to be produced.
  • Other companies and countries can start the process, assuming they have the technology.
  • Not only would greater production of vaccines ensure there were more available, it would also mean the vaccines would be cheaper, making it easier to vaccinate residents of developing countries.

Criticism of the Biden administration’s decision

  • But not everybody is a fan of the move to waive the vaccine patents.
  • For some, there is an obvious economic impact: if pharmaceutical companies can’t control the production of their product, they aren’t able to make as much profit.
  • In the hours after the Biden administration’s announcement, all four of the major US companies responsible for producing COVID-19 vaccines – BioNTech SE, Novavax, Inc., Moderna, Inc. and Pfizer Inc. – saw their stocks plummet.

Pfizer, Biontech, Novavax, Moderna shares plunge to session lows after U.S. backs waiving patent protections on Covid vaccines https://t.co/Wq9i3OsP1j pic.twitter.com/gEPwFw4yOg

— CNBC Now (@CNBCnow) May 5, 2021
  • But these drugmakers had other reasons for opposing the move.
  • They argued that the main cause of vaccine shortages wasn’t an unwillingness to share knowledge, but the lack of supplies and technological ability.
  • These companies have expressed concerns that an increase in the creation of vaccines by ill-equipped producers will result in a potentially inferior product.
  • Others have noted it could be another year or more before the waiver would have any effect on vaccine productions, meaning it would do next to nothing for struggling nations in the short-term.
  • The World Trade Organization (WTO) also would have to approve the waiver.

So, wait, the Biden administration didn’t waive patent rights?

  • No, the Biden administration doesn’t have the power to just toss out patents.
  • The waivers must be negotiated by the WTO, which is likely to take months.
  • It also isn’t as straightforward as simply waiving all patents for all vaccines. Countries like India and the US will need to bring proposals for how this would work and for which vaccines.
  • All 164 countries in the WTO would then have to agree to the waiver.
  • Considering that Germany just said it opposes the waiver, that might mean this is already dead in the water.
  • On the other hand, some believe that the Biden administration’s support for the waivers was about pressuring pharmaceutical companies into seeking out partnerships for vaccine production.
  • This would likely lead to an increase in vaccine production, which would lead to more and more countries getting vaccinated, even if the waivers never happen.

Have a tip or story? Get in touch with our reporters at [email protected]

Like TMS? Subscribe to our free daily newsletter

Related

Tags: Longer readNorth AmericaPolitics
ShareTweetShare

Latest Posts

period tracking apps

Why people in the US are deleting – and downloading – period tracking apps

June 30, 2022
Spotify R. Kelly

Spotify removed R. Kelly’s music in 2018, but then put it back up. What happens now that he’s a convicted sex offender?

June 30, 2022
Supreme Court abortion

The US Supreme Court’s abortion ruling

June 27, 2022

Here’s what’s happened at the G7 summit so far

June 27, 2022

The US orders Juul vapes off the market. Here’s what you need to know

June 24, 2022

US Senate agrees to fast-track new gun law

June 23, 2022

The fourth day of the January 6 hearings show Trump’s pressure campaign on election officials

June 22, 2022

Senator Ron Wyden proposes a tax increase on price-gouging oil companies

June 15, 2022

US House of Representatives holds primetime TV hearings on the January 6 attack on the Capitol. Here’s what you need to know

June 13, 2022

SUBSCRIBE TO THE TMS NEWSLETTER

By providing your email, you agree to our Privacy Policy

The Millennial Source Ltd. 2021

No Result
View All Result
  • Your daily briefing
  • About us
  • Explore
    • Startups
    • Climate change
    • Tech giants
    • Crypto
    • The future of work
    • Banking giants
    • Economy
  • Lifestyle
  • Human stories
  • TMS archives
  • Write for us
  • Contact
  • Privacy Policy & Terms

2022 The Millennial Source Ltd.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

string(24) "jsonld single post debug"
The Millennial Source
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.